Pezadeftide
Hexima’s lead product, pezadeftide, is a topical antifungal treatment for onychomycosis or fungal nail infections.
Now Recruiting
Hexima is recruiting volunteers for clinical trials of pezadeftide. Click below to find out more and to register your interest.
ShareCafe Webinar Recording
Latest NailMail Newsletter
Our CEO, Michael Aldridge, spoke at the ShareCafe Hidden Gems Webinar on 21 May 2021. You may view the recording of the webinar below or download the presentation (pdf).
NailMail is Hexima’s regular quarterly newsletter to shareholders, investors and interested parties.
ShareCafe Webinar Recording
Our CEO, Michael Aldridge, spoke at the ShareCafe Hidden Gems Webinar on 21 May 2021. You may view the recording of the webinar below or download the presentation (pdf).
Latest NailMail Newsletter
NailMail is Hexima’s regular quarterly newsletter to shareholders, investors and interested parties.
External Links
Take a look at these useful links to learn more about our industry.
